GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (OTCPK:LBPWQ) » Definitions » Net Issuance of Debt

4d pharma (4d pharma) Net Issuance of Debt : $0.00 Mil (TTM As of Dec. 2021)


View and export this data going back to 2021. Start your Free Trial

What is 4d pharma Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. 4d pharma's net issuance of debt for the six months ended in Dec. 2021 was $0.00 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2021 was $0.00 Mil.


4d pharma Net Issuance of Debt Historical Data

The historical data trend for 4d pharma's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma Net Issuance of Debt Chart

4d pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Net Issuance of Debt
Get a 7-Day Free Trial - - - - 11.96

4d pharma Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

4d pharma Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4d pharma Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of 4d pharma's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


4d pharma (4d pharma) Business Description

Traded in Other Exchanges
N/A
Address
9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma (4d pharma) Headlines

From GuruFocus

Update on Suspension of Trading

By Business Wire Business Wire 06-24-2022

4D pharma to Present at the H.C. Wainwright BioConnect Conference

By Business Wire Business Wire 01-05-2022